Cargando…

Prevalence of Celiac Disease in Patients with Primary Biliary Cholangitis

BACKGROUND: Primary biliary cholangitis (PBC) frequently coexists with other autoimmune diseases, including celiac disease (CeD). Although the prevalence of CeD is high among cohorts with PBC, few studies have directly compared this prevalence to those among individuals with other liver diseases (OL...

Descripción completa

Detalles Bibliográficos
Autores principales: Callichurn, Kashi, Cvetkovic, Lena, Therrien, Amélie, Vincent, Catherine, Hétu, Pierre-Olivier, Bouin, Mickael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898370/
https://www.ncbi.nlm.nih.gov/pubmed/33644676
http://dx.doi.org/10.1093/jcag/gwz039
_version_ 1783653850220068864
author Callichurn, Kashi
Cvetkovic, Lena
Therrien, Amélie
Vincent, Catherine
Hétu, Pierre-Olivier
Bouin, Mickael
author_facet Callichurn, Kashi
Cvetkovic, Lena
Therrien, Amélie
Vincent, Catherine
Hétu, Pierre-Olivier
Bouin, Mickael
author_sort Callichurn, Kashi
collection PubMed
description BACKGROUND: Primary biliary cholangitis (PBC) frequently coexists with other autoimmune diseases, including celiac disease (CeD). Although the prevalence of CeD is high among cohorts with PBC, few studies have directly compared this prevalence to those among individuals with other liver diseases (OLD). AIM: To compare the prevalence of CeD between a cohort with PBC and a cohort with OLD. METHODS: Retrospective study from January 2013 to December 2016. All consecutive patients with an anti-transglutaminase (tTG) assay requested by a hepatologist and a diagnosis of chronic liver disease were included. CeD diagnosis was confirmed by duodenal biopsies. RESULTS: We included 399 consecutive patients (53.1 years SD 14.0, 54.1% women), notably 51 individuals with PBC and 348 individuals with OLD. PBC group included significantly more women (90.2% versus 48.9% P < 0.0001). The prevalence of CeD was higher in the group with PBC compared to the group with OLD (11.8 versus 2.9%, P < 0.003). In the OLD group, the prevalence of CeD was comparable regardless of the etiologic subgroup (nonalcoholic steatohepatitis 2.7% versus alcoholic liver disease 4.3%, versus viral 1.5% versus other autoimmune liver diseases 3.3%, NS). The presence of gastrointestinal symptoms at the time of the tTG assay was comparable between PBC and OLD groups (31.4 versus 29.6%, NS). CONCLUSION: There is a higher prevalence of CeD in the PBC group compared to other liver diseases.
format Online
Article
Text
id pubmed-7898370
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-78983702021-02-25 Prevalence of Celiac Disease in Patients with Primary Biliary Cholangitis Callichurn, Kashi Cvetkovic, Lena Therrien, Amélie Vincent, Catherine Hétu, Pierre-Olivier Bouin, Mickael J Can Assoc Gastroenterol Original Articles BACKGROUND: Primary biliary cholangitis (PBC) frequently coexists with other autoimmune diseases, including celiac disease (CeD). Although the prevalence of CeD is high among cohorts with PBC, few studies have directly compared this prevalence to those among individuals with other liver diseases (OLD). AIM: To compare the prevalence of CeD between a cohort with PBC and a cohort with OLD. METHODS: Retrospective study from January 2013 to December 2016. All consecutive patients with an anti-transglutaminase (tTG) assay requested by a hepatologist and a diagnosis of chronic liver disease were included. CeD diagnosis was confirmed by duodenal biopsies. RESULTS: We included 399 consecutive patients (53.1 years SD 14.0, 54.1% women), notably 51 individuals with PBC and 348 individuals with OLD. PBC group included significantly more women (90.2% versus 48.9% P < 0.0001). The prevalence of CeD was higher in the group with PBC compared to the group with OLD (11.8 versus 2.9%, P < 0.003). In the OLD group, the prevalence of CeD was comparable regardless of the etiologic subgroup (nonalcoholic steatohepatitis 2.7% versus alcoholic liver disease 4.3%, versus viral 1.5% versus other autoimmune liver diseases 3.3%, NS). The presence of gastrointestinal symptoms at the time of the tTG assay was comparable between PBC and OLD groups (31.4 versus 29.6%, NS). CONCLUSION: There is a higher prevalence of CeD in the PBC group compared to other liver diseases. Oxford University Press 2020-01-02 /pmc/articles/PMC7898370/ /pubmed/33644676 http://dx.doi.org/10.1093/jcag/gwz039 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Canadian Association of Gastroenterology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
spellingShingle Original Articles
Callichurn, Kashi
Cvetkovic, Lena
Therrien, Amélie
Vincent, Catherine
Hétu, Pierre-Olivier
Bouin, Mickael
Prevalence of Celiac Disease in Patients with Primary Biliary Cholangitis
title Prevalence of Celiac Disease in Patients with Primary Biliary Cholangitis
title_full Prevalence of Celiac Disease in Patients with Primary Biliary Cholangitis
title_fullStr Prevalence of Celiac Disease in Patients with Primary Biliary Cholangitis
title_full_unstemmed Prevalence of Celiac Disease in Patients with Primary Biliary Cholangitis
title_short Prevalence of Celiac Disease in Patients with Primary Biliary Cholangitis
title_sort prevalence of celiac disease in patients with primary biliary cholangitis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898370/
https://www.ncbi.nlm.nih.gov/pubmed/33644676
http://dx.doi.org/10.1093/jcag/gwz039
work_keys_str_mv AT callichurnkashi prevalenceofceliacdiseaseinpatientswithprimarybiliarycholangitis
AT cvetkoviclena prevalenceofceliacdiseaseinpatientswithprimarybiliarycholangitis
AT therrienamelie prevalenceofceliacdiseaseinpatientswithprimarybiliarycholangitis
AT vincentcatherine prevalenceofceliacdiseaseinpatientswithprimarybiliarycholangitis
AT hetupierreolivier prevalenceofceliacdiseaseinpatientswithprimarybiliarycholangitis
AT bouinmickael prevalenceofceliacdiseaseinpatientswithprimarybiliarycholangitis